NAP1L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.442800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.348400E-02
Normal-vs-Stage2
3.942100E-03
Normal-vs-Stage3
5.529800E-02
Normal-vs-Stage4
2.422800E-01
Stage1-vs-Stage2
8.220200E-01
Stage1-vs-Stage3
4.711200E-01
Stage1-vs-Stage4
1.939440E-01
Stage2-vs-Stage3
5.266400E-01
Stage2-vs-Stage4
1.291040E-01
Stage3-vs-Stage4
1.361630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.918300E-03
Normal-vs-AfricanAmerican
1.242610E-01
Normal-vs-Asian
6.390500E-04
Caucasian-vs-AfricanAmerican
8.344400E-01
Caucasian-vs-Asian
3.056300E-02
AfricanAmerican-vs-Asian
1.351220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.141900E-03
Normal-vs-Female
4.197800E-03
Male-vs-Female
8.612800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.433990E-01
Normal-vs-Age(41-60Yrs)
1.929510E-02
Normal-vs-Age(61-80Yrs)
2.497800E-03
Normal-vs-Age(81-100Yrs)
9.604800E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.232600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.563400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.216800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.038560E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.829180E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.993200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.697400E-03
Normal-vs-Daily Drinker
3.702000E-03
Normal-vs-Weekly Drinker
8.220000E-03
Normal-vs-Occasional Drinker
5.321900E-02
Normal-vs-Social Drinker
1.287980E-02
Non Drinker-vs-Daily Drinker
9.991600E-01
Non Drinker-vs-Weekly Drinker
9.378600E-01
Non Drinker-vs-Occasional Drinker
7.557500E-02
Non Drinker-vs-Social Drinker
5.081800E-01
Daily Drinker-vs-Weekly Drinker
9.397800E-01
Daily Drinker-vs-Occasional Drinker
8.729700E-02
Daily Drinker-vs-Social Drinker
5.156800E-01
Weekly Drinker-vs-Occasional Drinker
1.215560E-01
Weekly Drinker-vs-Social Drinker
5.198600E-01
Occasional Drinker-vs-Social Drinker
3.290000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.953400E-01
Normal-vs-Grade 2
2.103200E-01
Normal-vs-Grade 3
7.275800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.546600E-01
Grade 1-vs-Grade 3
6.088600E-01
Grade 1-vs-Grade 4
3.953400E-01
Grade 2-vs-Grade 3
2.644400E-01
Grade 2-vs-Grade 4
2.103200E-01
Grade 3-vs-Grade 4
7.275800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.287660E-02
Normal-vs-NonDiabetic
1.897040E-03
Diabetic-vs-NonDiabetic
3.848800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.702870E-03
Normal-vs-NoPancreatitis
4.579800E-03
Pancreatitis-vs-NoPancreatitis
3.074000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.410060E-02
Normal-vs-N1
3.704400E-03
N0-vs-N1
3.757000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.67280000000459E-05
Normal-vs-TP53-NonMutant
3.001600E-02
TP53-Mutant-vs-TP53-NonMutant
7.575600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
